<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85661">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01990027</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-2013-0330</org_study_id>
    <nct_id>NCT01990027</nct_id>
  </id_info>
  <brief_title>Swiss Kidney Stone Cohort (SKSC)</brief_title>
  <acronym>SKSC</acronym>
  <official_title>Swiss Kidney Stone Cohort (SKSC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Swiss National Centre of Competence in Research Kidney Control of Homeostasis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Swiss National Centre of Competence in Research Kidney Control of Homeostasis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SKSC is a continuous database with the objective of a standardized diagnosis and
      monitoring of patients with kidney stones as well as the establishment of a Biobank.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is multi-site, standardized observation and characterization of
      kidney stone patients.

      Furthermore, an adequate structure should be established for the execution of studies with
      kidney stone patients, in order to then, if necessary, develop recommendations for useful
      monitoring or prophylactic measures, as well as new treatment options for kidney stone
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2024</completion_date>
  <primary_completion_date type="Anticipated">April 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Epidemiological characterization</measure>
    <time_frame>10 years</time_frame>
    <description>Epidemiological characterization of kidney stone patients</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Kidney Stone</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood; serum; urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a kidney stone episode
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Only patients that meet all of the following inclusion criteria can be included in this
        study:

          -  Signed Declaration of informed consent

          -  Male or female

          -  Recurrent kidney stone episodes (more than 1) or an individual kidney stone episode
             with one or several of the following risk factors:

          -  The first manifestation at the a minimum age of 25

          -  Positive family history

          -  Non-calcium oxalate stones

          -  Gastrointestinal disorders (e.g. gastric bypass surgery, inflammatory bowel disease,
             malabsorption etc.)

          -  Osteoporosis

          -  Nephrocalcinosis

          -  Single kidneyness

          -  Currently pregnant

          -  Gout

          -  Metabolic syndrome ( Diabetes Mellitus type I and II )

          -  Residual calculi (at least 3 months after the therapy)

          -  Bilateral or multiple stones

          -  Chronic urinary tract infection

          -  Chronic renal failure (eGFR lower than 60 ml/min.)

          -  Kidney transplant

        Exclusion Criteria:

        Patients with at least one of the following exclusion criteria may not take part in this
        study.

        -No signed Informed Consent form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olivier Bonny, MD-PhD</last_name>
    <email>Olivier.Bonny@unil.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carsten Wagner, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HUG</name>
      <address>
        <city>Geneva</city>
        <state>GE</state>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Ernandez, MD</last_name>
      <phone>+41 79 55 33284</phone>
      <email>Thomas.ernandez@hcuge.ch</email>
    </contact>
    <investigator>
      <last_name>Catherine Stoermann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Ernandez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USZ</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>CH-8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nilufar Mohebbi</last_name>
      <phone>+41 44 255 11 11</phone>
    </contact>
    <investigator>
      <last_name>Nilufar Mohebbi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universit√§tsspital Basel</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min-Jeong Kim, MD</last_name>
      <phone>+41613287368</phone>
      <email>Min-Jeong.Kim@usb.ch</email>
    </contact>
    <investigator>
      <last_name>Min-Jeong Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inselspital</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Fuster, MD</last_name>
      <phone>+41 31 632 97 72</phone>
      <email>daniel.fuster@ibmm.unibe.ch</email>
    </contact>
    <investigator>
      <last_name>Daniel Fuster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nasser Dhayat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHUV</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Bonny, MD</last_name>
      <phone>+41795564612</phone>
      <email>Olivier.Bonny@unil.ch</email>
    </contact>
    <investigator>
      <last_name>Olivier Bonny, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://nccr-kidney.ch</url>
  </link>
  <verification_date>October 2015</verification_date>
  <lastchanged_date>October 6, 2015</lastchanged_date>
  <firstreceived_date>October 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>kidney stone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
